Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
This study has been terminated.
Study NCT00324324 Information provided by OHSU Knight Cancer Institute
First Received on May 10, 2006. Last Updated on March 14, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Gestational Trophoblastic Tumor
Infection
Leukemia
Lymphoma
Myelodysplastic Syndromes
Neuroblastoma
Ovarian Cancer
Testicular Germ Cell Tumor
Additional conditions recognized in this trial
Bacterial Infections
Breast Neoplasms
Gestational Trophoblastic Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Multiple Myeloma
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms, Germ Cell and Embryonal
Neoplasms, Plasma Cell
Ovarian Neoplasms
Plasmacytoma
Preleukemia
Trophoblastic Neoplasms
More general conditions related to this trial
Adnexal Diseases
Blood Protein Disorders
Bone Marrow Diseases
Breast Diseases
Cardiovascular Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Ovarian Diseases
Paraproteinemias
Precancerous Conditions
Pregnancy Complications
Pregnancy Complications, Neoplastic
Skin Diseases
Urogenital Neoplasms
Vascular Diseases
Interventions listed in this trial
moxifloxacin hydrochloride
Placebo
Additional drug interventions recognized in this trial
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
More general drug interventions related to this trial
Anti-Infective Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Back to top of Main Content
